Bullish
BLSHAbout the company
Bullish, a global digital asset platform that provides market infrastructure and information services in United States. The company operates Bullish Exchange, a digital assets spot and derivatives exchange that integrates a central limit order book matching engine with automated market making to provide deep and predictable liquidity.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
2 / 11
NEUTRAL / FAIL
Median fair value
$21.82
-3.0% vs price
Models with upside
3 / 16
Positive margin of safety
Strongest signal
3 of 4 pass — Piotroski objects
Key risk
No clean pass — all 8 investors flag at least one growth criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | PASS | FAIL | FAIL | PASS | FAIL | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | ||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| Margin of Safety | N/A | N/A | N/A | N/A | +15.5% | -895.1% | N/A | -32.0% | +15.5% | -406.3% | +15.5% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-08-01–2026-11-01 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-08-01–2026-11-01 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-08-01–2026-11-01 Latest source filing: 2026-03-10 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage75% pass✓ 4✗ 1▾
3 of 4 pass — Piotroski objects
LT Debt / Total Assets Change0.82% -> 1.26%✗PiotroskiDecreased YoYTotal Debt / Shareholders' Equity0.03✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xNegative debt-to-equity (higher means less debt)-0.0311; #856/4210 (top 20.3%)✓AsnessTop 30% of eligible cross-sectionCurrent Assets / Current Liabilities29.28x✓SchlossCurrent ratio >= 1.50x (app cutoff)
Where It Falls Short
- Growth0% pass✓ 1✗ 11▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passEPS Growth Direction$10.63 (2023) -> $-5.99 (2025)✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency2/3 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth56.3%✓Ackman>= 5%Positive EPS Growth Frequency0/2 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Efficiency0% pass✗ 3▾
All 3 investors flag BLSH's efficiency
Revenue / Total Assets Change YoY82.10x -> 61.88x✗PiotroskiImproved YoYReinvestment Rate x ROICN/A (non-positive net income)✗AkreReinvestment Rate * ROIC > 10%ROE (5-year)1/3 years above 12% (latest -23.8%)✗SleepROE > 12% in a majority of years - Profitability6% pass✓ 4✗ 31▾
15 of 16 flag BLSH's profitability — Graham, Buffett, Lynch +12 more
Return on Equity-23.8%✗Munger> 15%✓AkreROE > 20% (3-year avg)Positive EPS (10 years)2/4 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)2/4 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)26.9%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy✗BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-23.8%✗Lynch> 15%Net Income / Total Assets-19.33%✗PiotroskiROA > 0ROA Change YoY2.58% -> -19.33% (delta: -21.90%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=0.72%, ROA=-19.33%✓PiotroskiCFO/Assets > ROAPre-Tax Income / Revenue-0.3%✗Dreman>= 8%Net Income / Shareholders' Equity-23.8%✗Dreman> 12%Margin of SafetyP/TBV=1.1x✓PabraiP/TBV < 1.5 or P/E < 15ROE (high and growing)FY2023: ROE=101.3%; FY2024: ROE=3.3%; FY2025: ROE=-23.8%✗AkreLatest 3 consecutive FYs: ROE > 15% in eachDiscount to Intrinsic Value15.5% (IV=$26.60 vs Price=$22.49)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency2/3 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity-23.8%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingROE (5-year)1/3 years above 12% (latest -23.8%)✗SleepROE > 12% in a majority of yearsNet income / market capitalization-22.42%; #4624/6340 (top 72.9%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+1.98%; #3268/3702 (top 88.3%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity-23.78%; #3771/5226 (top 72.2%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation8% pass✓ 9✗ 17▾
11 of 12 flag BLSH's valuation — Lynch, Dreman, Munger +8 more
Price / Tangible Book Value per Share1.1x✓Dreman< 1.2x✗SchlossP/TBV <= 1.00x (app cutoff)Price / Book Value per Share1.1x✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Price / 3-yr avg EPS12.7x✓Graham<= 15xPrice-to-Tangible-Book Ratio1.1x✓Graham<= 1.5xP/E x P/TBV13.80✓Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)118.5x✗Dreman< 8xValuation Reasonableness✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldFCF Yield=0.5%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=1.1x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value15.5% (IV=$26.60 vs Price=$22.49)✗Marks>= 20% below intrinsic valuePrice / FCF per Share181.4x✗Ackman<= 25Price vs. Trailing Low100% of trailing low ($22.49)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-22.42%; #4624/6340 (top 72.9%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.9430; #1593/6449 (top 24.7%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+71.7802; #100/5247 (top 1.9%)✓OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+0.55%; #2456/4519 (top 54.3%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-37.92%; #4726/6202 (top 76.2%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts21% pass✓ 3✗ 11▾
Split decision: 11 FAIL · 3 PASS · 2 NEUTRAL
Overall verdict✓GrahamPASS (4/7)✗BuffettFAIL (1/6)✗LynchFAIL (1/4)✗PiotroskiFAIL (F-Score 2)✗DremanFAIL (2/9)✗MungerFAIL (0/3)✗PabraiFAIL (1/3)✓AkrePASS (2/5)✗MarksFAIL (1/4)✗AckmanFAIL (2/8)✓TempletonPASS (4/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked) - Cash Flow30% pass✓ 4✗ 8▾
7 of 10 flag BLSH's cash flow — Buffett, Dreman, Pabrai +4 more
Free Cash Flow Proxy✗BuffettPositive and growingFCF Positive and Growing$18.7M✓LynchPositive and growingOperating Cash Flow$28.6M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=0.72%, ROA=-19.33%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)118.5x✗Dreman< 8xP/E or FCF YieldFCF Yield=0.5%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive1/3 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap0.6%✗Ackman>= 4%Price / FCF per Share181.4x✗Ackman<= 25Positive Operating Cash Flow frequency1/3 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$18.7M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+0.55%; #2456/4519 (top 54.3%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models50% pass✓ 3✗ 3▾
Models split on BLSH at $22.49 — fair values range $2.26–$26.60
Dreman fair value$26.60✓Dreman+15.5% margin vs $22.49Munger fair value$2.26✗Munger-895.1% margin vs $22.49Akre fair value$17.04✗Akre-32.0% margin vs $22.49Marks fair value$26.60✓Marks+15.5% margin vs $22.49Ackman fair value$4.44✗Ackman-406.3% margin vs $22.49Templeton fair value$26.60✓Templeton+15.5% margin vs $22.49
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.
Shareholder Return
Fiscal 2025
Issued 33.9% of shares last year, 34.1% issued over two.
- Buybacks
- —
- Dividends
- $0
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
|
|---|---|---|---|---|
| Market Cap | $3.4Bcurrent | $6.7Best. | -- | -- |
| Revenue | $244.8B↓2% | $250.2B↑115% | $116.5B | -- |
| Operating Income | -- | -- | -- | -- |
| Net Income | -$764.7M↓1074% | $78.5M↓94% | $1.3B | -- |
| EPS (Diluted) | $-5.99↓981% | $0.68↓94% | $10.63 | -- |
| Gross Margin | 0.0%↓17% | 0.0%↓38% | 0.1% | — |
| Operating Margin | — | — | — | — |
| ROE | -23.8%↓824% | 3.3%↓97% | 101.3% | — |
| Total Debt | $100.0M↑100% | $50.0M | -- | -- |
| Shareholders' Equity | $3.2B↑35% | $2.4B↑86% | $1.3B↓32% | $1.9B |
| Current Ratio | 29.28↓14% | 34.24 | — | — |
| Debt / Equity | 0.03↑49% | 0.02 | — | — |
| Operating Cash Flow | $28.6M↑196% | -$30.0M↑76% | -$126.7M | -- |
| Free Cash Flow | $18.7M↑162% | -$30.4M↑76% | -$127.6M | -- |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Banking
BLSH vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MITSUBISHI UFJ FINANCIAL GROUP INCMUFG | $245.7B | $21.83 | $74.2B | $10.8B | 8.8% | 1.12 | 19.9% | — | 2/7 | 1/6 | 1/4 | F-Score 5 | 3/9 |
| AMERICAN EXPRESS COAXP | $215.0B | $320.60 | $41.3B | $10.8B | 32.4% | 1.68 | — | — | 2/7 | 3/6 | 3/4 | F-Score 4 | 3/9 |
| Banco Santander, S.A.SAN | $175.9B | $12.21 | — | $16.6B | 12.5% | 0.02 | — | — | 2/7 | 1/6 | 2/4 | F-Score 4 | 5/9 |
| BARCLAYS BANK PLCATMP | $82.1B | $35.04 | $13.1B | $6.3B | 7.5% | 0.01 | — | — | 2/7 | 1/6 | 0/4 | F-Score 7 | 4/9 |
| BARCLAYS PLCBCS | $76.0B | $22.87 | $15.0B | $9.7B | 9.2% | 0.02 | — | — | 1/7 | 0/6 | 0/4 | F-Score 7 | 2/9 |
| FIRST CITIZENS BANCSHARES INC /DE/FCNCA | $25.7B | $2324.25 | $9.5B | $2.2B | 9.9% | 1.62 | — | — | 5/7 | 3/6 | 1/4 | F-Score 5 | 2/9 |
| KEYCORP /NEW/KEY | $22.7B | $21.46 | $7.5B | $1.8B | 9.0% | 0.49 | — | — | 2/7 | 1/6 | 1/4 | F-Score 6 | 4/9 |
| WEBSTER FINANCIAL CORPWBS | $12.6B | $77.57 | $2.9B | $1.0B | 10.6% | 0.08 | 50.7% | — | 2/7 | 1/6 | 1/4 | F-Score 7 | 2/9 |